Price
No data yet.
Social Signal Score
Revenue
$131.95M+74.56%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- John Walter Hanna Jr.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Employees
- 763
- Beta
- 2.42
- Country
- US
- Piotroski score
- 7 / 9 (Strong)
- Altman Z-score
- 13.70
Financials
Revenue
$131.95M+74.6%Net Income
$110.64MEBITDA
$4.30MFree Cash Flow
$28.75MEPS (diluted)
$2.07Shares Outstanding (diluted)
53.42M+1.4%Operating Expenses
$96.72MCash & Debt
$373.64MReturn of Capital
$0.00Revenue by Segment (annual)
$322.87MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $379.81M | $-21.35M | $-0.40 |
| 2024 | $333.79M | $52.55M | $1.00 |
| 2023 | $280.32M | $-190.28M | $-3.54 |
| 2022 | $321.79M | $-76.61M | $-1.44 |
| 2021 | $296.40M | $-30.66M | $-0.59 |
| 2020 | $192.19M | $-18.71M | $-0.40 |
| 2019 | $127.07M | $-21.97M | $-0.52 |
| 2018 | $76.57M | $-46.76M | $-1.31 |
| 2017 | $48.32M | $-55.47M | $-2.38 |
| 2016 | $40.63M | $-39.47M | $-2.39 |
| 2015 | $28.14M | $-13.71M | $-1.16 |
| 2014 | $27.31M | $781.0K | $0.13 |
| 2013 | $22.10M | $-3.54M | $-0.48 |
| 2012 | $20.45M | $-5.06M | $-0.69 |
Valuation
CDNAhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
80Social Signal Score
Mentions (1)
- Newsgurufocus.com·8h ago·Negative
Ron Baron Trims CareDx Inc (CDNA) Stake -- Shares Trade 86% Above GF Value On June 30, 2026, Ron Baron (Trades, Portfolio) executed a significant reduction in the firm's position in CareDx Inc (NASDAQ: CDNA), selling 1,399,083 shares at
View source ↗
Earnings
Tue, Nov 3(in 2 months)
Consensus estimate $0.24 per share
Typical surprise +138.9% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Jul 30$0.37 vs $0.23beat
- Tue, Apr 28$0.34 vs $0.11beat
- Tue, Feb 24$0.12 vs $0.02beat
- Tue, Nov 4$0.03 vs $-0.08beat
- Wed, Aug 6$-0.16 vs $-0.10miss
- Wed, Apr 30$-0.19 vs $-0.21beat
Estimates and results for CDNA via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by CDNA officers and directors.
- Bought
- —
- Sold
- $13.3m
0 trades
26 trades
- Bickerstaff Georgesold
- Novack Jeffrey Adamsold
- Novack Jeffrey Adamsold
- Cournoyer Christinesold
- Goldberg Michaelsold
- Hanna John Walter Jrsold
- Hanna John Walter Jrsold
- Valantine Hannahsold
74 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.